Abstract:AbstractIntroductionMany clinical trials showed favorable effects of high-doses supplemental n-3 polyunsaturated fatty acids (PUFA) on cardio-metabolic risk factors. However, limited studies examined the prospective associations of circulating n-3 PUFA with body fat and its distribution, metabolic syndrome (MS), carotid atherosclerosis, and nonalcoholic fatty liver disease (NAFLD) in subjects with habitual diets containing low levels of n-3 PUFA.Materials and MethodsThis community-based prospective study enrolled 4048 participants (40–75 years) at baseline (2008–2010, 2013) from Guangzhou, China. They were followed-up approximately once every 3 years. Fatty acids in erythrocyte membranes were measured at baseline. We determined metabolic syndrome factors, body fat by DXA scanning, carotid intima-media thickness (IMT) and NAFLD by ultrasound at the visits. General information, anthropometric indices, habitual dietary intake and other covariates were assessed at each visit.ResultsAmong the total 4048 subjects, 3075 and 2671 subjects had erythrocyte n-3 PUFA data and completed the first and second follow-ups. Generally, erythrocyte n-3 PUFA were favorably associated with body fat (particularly at abdomen) and its changes, and with the presence and incidence of MS, type 2 diabetes, carotid IMT thickening. The participants with the highest (vs lowest) quartile of n-3 PUFA were associated with -5.81% fat mass (p < 0.001) and -2.11% of fat mass change at the abdomen (Android) area. The adjusted hazards ratios (95% CI) for the highest (vs. lowest) group were 0.74 (0.61, 0.89) (total n-3 PUFA), 0.71 (0.59, 0.86) (docosahexaenoic acid, DHA), 0.78 (0.65, 0.95) (docosapentaenoic acid, DPA), 1.96 (1.60, 2.40) (gamma-linolenic acid, GLA) for MS; 0.70(0.55, 0.90) (total n-3 PUFA), 0.67(0.52,0.87) (DHA) and 0.73(0.57,0.93) (DPA) for bifurcation IMT thickening, 0.57(0.38, 0.86) (eicosapentaenoic acid, EPA) and 0.63 (0.41, 0.95) (DPA) for type 2 diabetes, and 1.18 (1.09, 1.33) (DHA) for alleviated NAFLD. Both higher levels of total and individual marine n-3 PUFAs (DHA, EPA and DPA) were associated with lower blood pressure at baseline and lower changes in diastolic and systolic blood pressure over the follow-up period. Plant n-3 PUFA (α-linolenic acid, ALA) largely had less significant association with the above-mentioned indices as compared with marine n-3 PUFAs.DiscussionHigher proportions of erythrocyte n-3 PUFA (particularly marine sources) was associated with lower body fat, blood pressure and their changes, and lower risks of MS, type 2 diabetes and bifurcation IMT thickening, but higher chance of alleviated NAFLD in middle-aged and older adults.

Erythrocyte Membrane Polyunsaturated Fatty Acids Are Associated with Incidence of Metabolic Syndrome in Middle-Aged and Elderly People–An 8.8-Year Prospective Study

Erythrocyte PUFAs, Circulating Acylcarnitines, and Metabolic Syndrome Risk: a Prospective Study in Chinese.

Association between n-3 polyunsaturated fatty acids in erythrocytes and metabolic syndrome in Chinese men and women

N-3 Polyunsaturated Fatty Acids and Metabolic Syndrome Risk: A Meta-Analysis

Association of Erythrocyte N-3 Fatty Acids with DXA-body Fat and Cardio-Metabolic Indices in Middle-Aged and Elderly Adults: a Prospective Study

Association of Erythrocyte N-3 Polyunsaturated Fatty Acids with Incident Type 2 Diabetes in a Chinese Population.

Plasma glycerophospholipid profile, erythrocyte n–3 PUFAs, and metabolic syndrome incidence: a prospective study in Chinese men and women

Association Between Erythrocyte Polyunsaturated Fatty Acids and Incidence of Metabolism Syndrome and Subclinical Carotid Atherosclerosis: A Population Prospective Study (OR19-08-19).

The associations of erythrocyte membrane polyunsaturated fatty acids with skeletal muscle loss: A prospective cohort study

Erythrocyte Membrane N-3 Polyunsaturated Fatty Acids Are Inversely Associated with the Presence and Progression of Nonalcoholic Fatty Liver Disease in Chinese Adults: a Prospective Study

Marine N-3 Polyunsaturated Fatty Acids Are Inversely Associated With Risk Of Type 2 Diabetes In Asians: A Systematic Review And Meta-Analysis

Association Between Erythrocyte Membrane N-3 and N-6 Polyunsaturated Fatty Acids and Carotid Atherosclerosis: A Prospective Study

Higher Erythrocyte N-3 Polyunsaturated Fatty Acid Were Associated with a Better Profile of DXA-derived Body Fat and Fat Distribution in Adults.

Higher Erythrocyte N–3 PUFAs Are Associated with Decreased Blood Pressure in Middle-Aged and Elderly Chinese Adults

Plasma Signature Metabolites of Dietary Fat Intake Characterize Associations with Prevalent Metabolic Syndrome

Association of Serum Fatty Acid and Estimated Desaturase Activity with Hypertension in Middle-Aged and Elderly Chinese Population

Predictive Value of Uric Acid Regarding Cardiometabolic Disease in a Community-Dwelling Older Population in Shanghai: A Cohort Study

Associations of Circulating Gamma-Linolenic Acid and Cardiometabolic Health in Chinese Adults: A Prospective Study

Serum Levels of Polyunsaturated Fatty Acids Are Low in Chinese Men with Metabolic Syndrome, Whereas Serum Levels of Saturated Fatty Acids, Zinc, and Magnesium Are High

Exploratory serum fatty acid patterns associated with blood pressure in community-dwelling middle-aged and elderly Chinese

Plasma Phospholipids N-3 Polyunsaturated Fatty Acid is Associated with Metabolic Syndrome.